It is a pleasure to serve under your chairmanship, Mrs Harris. I welcome the hon. Member for South Northamptonshire (Sarah Bool) to this place and thank her for securing the debate and sharing her personal experience. With over 4.9 million people in the UK having diabetes and 2 million at risk of type 2 diabetes, tackling preventable ill health is crucial. The Government aims to ensure best possible care for those with types 1 and 2 diabetes, supporting healthier lives regardless of location. Annual diabetes reviews cover eight processes recommended by NICE; however, only 42% received all checks in 2019 before the pandemic. NHS invested £14.5 million over two years to support up to 140,000 people aged 18-39 with additional tailored health checks for diabetes management and stigma reduction. Technology such as real-time continuous glucose monitoring and hybrid closed loop systems are critical in managing type 1 and type 2 diabetes; NHS England has developed a national strategy with guidance for phased uptake of these life-changing technologies, prioritizing children, young people, pregnant women, and adults using pumps. The Minister addressed concerns about access to GLP-1 medications like Ozempic by stating the Government works closely with manufacturers to resolve global supply issues. On prevention, Healthier You NHS diabetes prevention programme supports lifestyle changes reducing risk of type 2 diabetes by 40%. A focused engagement campaign raises awareness among high-risk groups, and the type 2 diabetes path to remission programme provides a low calorie diet for recent diagnoses. The Government looks forward to future policy making informed by ongoing studies like ELSA and University of Bristol's research.